Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
P2i is a private UK nanotechnology company that develops and commercializes ultra-thin plasma-applied coatings designed to protect electronic devices and materials from liquid damage and corrosion. Its core offering is a PECVD-based conformal coating technology used at the component and product level, particularly for electronics manufacturers seeking waterproofing and environmental protection. The company appears to operate as a materials and manufacturing technology provider rather than as a drug developer, biotech, pharma, or healthcare company. P2i serves industrial markets including consumer electronics and related sectors, and emphasizes sustainability by extending product life and reducing waste. For life-science-focused diligence, P2i is best classified as a non-health industrial technology company with limited relevance to therapeutic pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P2i.